Home/ Supplements/ Iron/ Taron-C DHA

Taron-C DHA

product on market Capsule Trigen Laboratories Safety: 98/100
98/100

This product looks safe

  • Ferrous Fumarate: 53.5mg is 1.2× the Tolerable Upper Intake Level (45mg)
  • 87% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula combines iron sources and Vitamin C to support hemoglobin synthesis and iron absorption, alongside B vitamins and folic acid for red blood cell formation. There is strong evidence supporting these ingredients for managing iron deficiency and anemia. The profile maintains a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Ferrous Fumarate: 53.5mg is 1.2× the Tolerable Upper Intake Level (45mg)

Label

Product Label

Label for Taron-C DHA
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
87%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

53.5 mg (297% DV)
Exceeds UL by 1.2× (UL: 45 mg) 505 studies (A:17, B:273)
38 mg (211% DV)
4.8× RDA — above typical dose (UL: 45 mg) 505 studies (A:17, B:273)
Vitamin C
25 mg (42% DV)
1 mg (125% DV)
2.5× RDA — within safe limits 226 studies (A:10, B:105)
2 mg (118% DV)
1.7× RDA — within safe limits 76 studies (A:0, B:33)
3 mg (150% DV)
2.3× RDA — within safe limits 13 studies (A:0, B:1)
1.8 mg (9% DV)
Within RDA (0.1× RDA) 196 studies (A:5, B:63)
5 mg (50% DV)
Within RDA (1.0× RDA) 2 studies — no high-quality reviews
25 mg (1000% DV)
19.2× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
300 mcg (100% DV)
10.0× RDA — above typical dose 27 studies (A:0, B:11)
12.5 mcg (156% DV)
5.2× RDA — above typical dose 139 studies (A:1, B:44)
2 mg (100% DV)
2.2× RDA — within safe limits 37 studies (A:0, B:11)
5 mg (1% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
10 mg (67% DV)
Within RDA (0.9× RDA) 263 studies (A:6, B:134)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended Use: Adults (persons over 12 years of age), One (1) capsule daily, between meals, or as prescribed by a physician. Do not exceed recommended dosage.

Warnings & Precautions

Do not exceed recommended dosage.

Do not administer to children under the age of 12.

Warning: Accidental overdose of iron-containing products is a leading cause of fetal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Call your doctor about side effects. You may report side effects by calling 888 9 TRIGEN (888-987-4436).

Keep out of the reach of children.

Formulation Notes

Description: Taron C DHA is a prescription prenatal vitamin-mineral preparation containing omega-3 fatty acids supplements.

With ascorbic acid precursors

Additional Information

Storage: Store at 20(0)-25(0)C (68-77(0)F), excursions permitted to 15(0)-30(0)C (59(0)-85(0)F) [see USP controlled room temperature].

Rev. 05/13

Also containing Ascorbic Acid precursors (1) Acid Metabolites including Niacinamide Ascorbate, Calcium Ascorbate, Magnesium Ascorbate, Potassium Ascorbate, and Sodium Ascorbate (2) Basic Amino Acids including Lysine Acetate; (3) Flavonoids including Hesperidin; and (4) Glutathione.

13811-536-30 Rx only

Metadata

Product Details

UPC / SKU3 13811 53630 0
DSLD Entry Date2018-02-23
Product TypeOther Combinations
FormCapsule
DSLD ID82216
Data Updated2026-04-11
Research

Research Evidence

566
Research Sources
56
Avg Quality
240
Meta Analysis
100
Clinical Trial
74
Systematic Review
71
Guideline
58
Rct
11
Cochrane Review
4
Regulatory Source
2
Other
2
Narrative Review
1
Observational
1
Openfda Safety
A Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency
Meta Analysis Nature medicine 2025 PubMed DOI
A Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Serum or plasma ferritin concentration as an index of iron deficiency and overload
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Non-invasive diagnostic tests for Helicobacter pylori infection
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
A Wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Fortification of condiments and seasonings with iron for preventing anaemia and improving health
Meta Analysis The Cochrane database of systematic reviews 2023 PubMed DOI
A Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: US Preventive Services Task Force Recommendation Statement.
Guideline JAMA 2024 PubMed DOI
A Psychiatric and cognitive outcomes of iron supplementation in non-anemic children, adolescents, and menstruating adults: A meta-analysis and systematic review
Meta Analysis Neuroscience and biobehavioral reviews 2025 PubMed DOI
View all evidence for Iron →
Compare

Similar Products

View all Iron products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.